Valneva SE VALN
NASDAQ VALN
$6.92 -0.14 (-1.98%)
As of: Sep 4, 2026 · 1:33 PM EDT

Valneva SE (VALN) Interest Expenses (2021 - 2026)

Valneva SE (VALN) posted Interest Expenses of -$6.0 million for Q1 2026, down 120.82% sequentially from $28.6 million in Q4 2025, and up 5.21% YoY from -$5.7 million in Q1 2025.

Analysis

Valneva SE (VALN) Interest Expenses (2021 - 2026) Analysis & Trends

Valneva SE has reported Interest Expenses for 7 years, with the latest figure at -$6.0 million in Q1 2026.

  • Quarterly Interest Expenses rose 5.21% year-over-year to -$6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.1 million (up 93.34% YoY) and the FY2025 annual result came in at $48.8 million, up 87.76% from the prior year.
  • Interest Expenses declined to -$6.0 million in Q1 2026 per VALN's latest filing, from $28.6 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $5.8 billion in Q3 2023 and troughed at -$5.8 billion in Q2 2023.
  • A 5-year average of $6.5 million and a median of -$3.7 million in 2022 frame the typical range for Interest Expenses.
  • The widest YoY moves for Interest Expenses: up 111145.84% in 2023, down 156679.69% in 2023.
  • Over 5 years, Interest Expenses stood at $33.1 million in 2022, then grew by 4.29% to $34.5 million in 2023, then sank by 80.5% to $6.7 million in 2024, then surged by 325.35% to $28.6 million in 2025, then tumbled by 120.82% to -$6.0 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered -$6.0 million, $28.6 million, and $33.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - 23.78 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 93.62 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 20.27 Mn
10 Valneva SE 581.90 Mn 440.64 Mn 1.86 Mn -6.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.04 Mn
Mar 31, 2026 -5.96 Mn
Dec 31, 2025 28.64 Mn
Sep 30, 2025 33.77 Mn
Jun 30, 2025 -6.35 Mn
Mar 31, 2025 -6.29 Mn
Dec 31, 2024 6.73 Mn
Sep 30, 2024 32.60 Mn
Jun 30, 2024 -5.32 Mn
Mar 31, 2024 -7.65 Mn
Dec 31, 2023 -11.67 Mn
Sep 30, 2023 -3.92 Mn
Jun 30, 2023 -4.12 Mn
Mar 31, 2023 -5.47 Mn
Dec 31, 2022 -5.77 Mn
Sep 30, 2022 -5.24 Mn
Jun 30, 2022 -3.71 Mn
Mar 31, 2022 -5.30 Mn
Dec 31, 2021 -5.52 Mn
Sep 30, 2021 -4.37 Mn